[CONSIDERATIONS ON THE USE OF RIFAMYCIN SV IN SOME DISEASES OF THE BILIARY TRACT].
D000410:Alanine Transaminase; D000469:Alkaline Phosphatase / Q000097:blood*; D001219:Aspartate Aminotransferases; D001659:Biliary Tract; D001663:Bilirubin; D002761:Cholangitis; D002764:Cholecystitis; D002784:Cholesterol / Q000097:blood*; D005705:Gallbladder Diseases; D006505:Hepatitis; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007931:Leucyl Aminopeptidase; D007958:Leukocyte Count; D008055:Lipids / Q000097:blood*; D008111:Liver Function Tests; D008660:Metabolism; D012294:Rifamycins; D013448:Sulfobromophthalein
D008055:Lipids; D012294:Rifamycins; D013448:Sulfobromophthalein; D002784:Cholesterol; C023808:rifamycin SV; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D007931:Leucyl Aminopeptidase; D001663:Bilirubin
ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BLOOD ALKALINE PHOSPHATASE; BLOOD CHOLESTEROL; BLOOD LIPIDS; CHOLANGITIS; CHOLECYSTITIS; GALLBLADDER DISEASES; HEPATITIS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; LEUCINE AMINOPEPTIDASE; LEUKOCYTE COUNT; LIVER FUNCTION TESTS; METABOLISM; RIFOMYCIN; SULFOBROMOPHTHALEIN
CONSIDERAZIONI SULL'IMPIEGO DELLA RIFAMICINA SV IN ALCUNE AFFEZIONI DELLE VIE BILIARI.